XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.2
Certain Transactions - Other Transactions - Additional Information (Detail) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended 6 Months Ended
Jun. 12, 2023
Oct. 31, 2021
Aug. 31, 2021
Dec. 31, 2016
Sep. 30, 2022
Jun. 30, 2022
Dec. 31, 2021
Jun. 30, 2023
Dec. 20, 2022
Johnson And Johnson [Member] | Settlement And License Agreement Alvotech And Teva [Member]                  
Noncash or Part Noncash Acquisitions [Line Items]                  
Maximum entry date for granting license entry Feb. 21, 2025                
Takeda [Member]                  
Noncash or Part Noncash Acquisitions [Line Items]                  
Upfront payment       $ 30          
Milestone payment       20   $ 25      
Collaborative agreement milestone payments       $ 519          
Alvotech [Member]                  
Noncash or Part Noncash Acquisitions [Line Items]                  
Collaborative agreement milestone payments               $ 400  
Alvotech [Member] | Subordinated Convertible Bonds [Member]                  
Noncash or Part Noncash Acquisitions [Line Items]                  
Debt instrument face amount                 $ 40
MedinCell [Member]                  
Noncash or Part Noncash Acquisitions [Line Items]                  
Milestone payment         $ 3        
Collaborative agreement milestone payments     $ 105            
MODAG [Member]                  
Noncash or Part Noncash Acquisitions [Line Items]                  
License agreement potential aggregate milestone payments amount   $ 30              
MODAG [Member] | Research and Development Expense [Member]                  
Noncash or Part Noncash Acquisitions [Line Items]                  
Milestone payment             $ 10